Maria Antonia Zancanaro de Figueiredo

Maria Antonia Zancanaro de Figueiredo

Auto-generated profile, based on publicly available information

Maria Antonia Zancanaro de Figueiredo

Pontifícia Universidade Católica do Rio Grande do Sul

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
MPMaria Noel Marzano Rodrigues Petruzzi
Maria Noel Marzano Rodrigues Petruzzi
KCKaren Cherubini
Karen Cherubini
Fernanda Gonçalves SalumFernanda Gonçalves Salum
Fernanda Gonçalves Salum
MFMaria Antonia Zancanaro de Figueiredo
Maria Antonia Zancanaro de Figueiredo
Oral squamous cell carcinoma (OSCC) accounts over 90% of malignant neoplasms of the oral cavity. This pathological entity is associated to a high mortality rate that has remained unchanged over the past decades. Tumour-associated macrophages (TAMs) are believed to have potential involvement in OSCC progression. However, the molecular networks involved in communication between stroma and cancer cells have not yet been fully elucidated. The role of M2 polarized cells in oral carcinogenesis is supported by a correlation between TAMs accumulation into OSCC stroma and poor clinical outcome. Signalling pathways such as the NF-κB and cytokines released in the tumour microenvironment promote a bidirectional cross-talk between M2 and OSCC cells. These interactions consequently result in an increased proliferation of malignant cells and enhances aggressiveness, thus reducing patients’ survival time. Here, we present a comprehensive review of the role of interleukin (IL)-1, IL-4, IL-6, IL-8, IL-10 and the receptor tyrosine kinase Axl in macrophage polarization to an M2 phenotype and OSCC progression. Understanding the molecular basis of oral carcinogenesis and metastatic spread of OSCC would promote the development of targeted treatment contributing to a more favourable prognosis.

8 August 2018 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MKMariana Klein
Mariana Klein
JBJuliane de Quadros De Bortolli
Juliane de Quadros De Bortolli
FGFrancisco Silveira Guimarães
Francisco Silveira Guimarães
FSFernanda Gonçalves Salum
Fernanda Gonçalves Salum
KCKaren Cherubini
Karen Cherubini
MFMaria Antonia Zancanaro de Figueiredo
Maria Antonia Zancanaro de Figueiredo

12 February 2017 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
LCL. F. Cuba
L. F. Cuba
FSF. G. Salum
F. G. Salum
KCKaren Cherubini
Karen Cherubini
MFM. A. Z. Figueiredo
M. A. Z. Figueiredo

1 September 2016 in Dentomaxillofacial Radiology
Verified
Journal Article
Open access
VKValesca Koth
Valesca Koth
MFMaria Antonia Figueiredo
Maria Antonia Figueiredo
Fernanda Gonçalves SalumFernanda Gonçalves Salum
Fernanda Gonçalves Salum
KCKaren Cherubini
Karen Cherubini
The present work aimed to review the literature focusing on diagnostic criteria for bisphosphonate-related osteonecrosis of the jaw (BRONJ) and its implications regarding the management of the disease. Since the report of the first cases, BRONJ concepts, diagnostic criteria and guidelines have been changed. Presence of bone exposure in the oral cavity was at first a sine qua non condition for diagnosis. However, it seems that the great concern now is the possibility of occurrence of BRONJ without this feature. Some authors warn that the bone exposure criterion leads to late diagnosis and poor response to treatment. Meanwhile, some radiographic features, such as bone sclerosis, have been postulated as early signs of the disease. Criticisms have also been raised about the clinical staging system of BRONJ. While there is no consensus on the subject, common sense recommends treating symptomatic patients taking bisphosphonate as having BRONJ despite the absence of bone exposure; and asymptomatic patients must ...

7 March 2013 in Gerodontology
Verified
Journal Article
Closed access
PDF file
CMClarissa C. G. Medeiros
Clarissa C. G. Medeiros
KCKaren Cherubini
Karen Cherubini
FSFernanda G. Salum
Fernanda G. Salum
MFMaria Antonia Z. de Figueiredo
Maria Antonia Z. de Figueiredo

23 December 2015 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
LCLetícia de Freitas Cuba
Letícia de Freitas Cuba
AFAroldo Braga Filho
Aroldo Braga Filho
KCKaren Cherubini
Karen Cherubini
FSFernanda Gonçalves Salum
Fernanda Gonçalves Salum
MFMaria Antonia Zancanaro de Figueiredo
Maria Antonia Zancanaro de Figueiredo